An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission
- 2 December 2007
- journal article
- research article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 4 (1) , 42-50
- https://doi.org/10.1038/nchembio.2007.55
Abstract
Muscarinic acetylcholine receptors (mAChRs) provide viable targets for the treatment of multiple central nervous system disorders. We have used cheminformatics and medicinal chemistry to develop new, highly selective M4 allosteric potentiators. VU10010, the lead compound, potentiates the M4 response to acetylcholine 47-fold while having no activity at other mAChR subtypes. This compound binds to an allosteric site on the receptor and increases affinity for acetylcholine and coupling to G proteins. Whole-cell patch clamp recordings revealed that selective potentiation of M4 with VU10010 increases carbachol-induced depression of transmission at excitatory but not inhibitory synapses in the hippocampus. The effect was not mimicked by an inactive analog of VU10010 and was absent in M4 knockout mice. Selective regulation of excitatory transmission by M4 suggests that targeting of individual mAChR subtypes could be used to differentially regulate specific aspects of mAChR modulation of function in this important forebrain structure.Keywords
This publication has 42 references indexed in Scilit:
- Cinacalcet: An oral calcimimetic agent for the managementof hyperparathyroidismClinical Therapeutics, 2005
- Thiochrome Enhances Acetylcholine Affinity at Muscarinic M4 Receptors: Receptor Subtype Selectivity via Cooperativity Rather than AffinityMolecular Pharmacology, 2004
- Muscarinic agonist potencies at three different effector systems linked to the M2 or M3 receptor in longitudinal smooth muscle of guinea‐pig small intestineBritish Journal of Pharmacology, 2002
- Treating Alzheimer's Disease With Cholinesterase Inhibitors: What Have We Learned So Far?International Psychogeriatrics, 2002
- Rivastigmine for the Treatment of Dementia and Visual Hallucinations Associated with Parkinson's Disease: A Case SeriesCurrent Medical Research and Opinion, 2002
- The Effects of Metrifonate on the Cognitive, Behavioral, and Functional Performance of Alzheimer's Disease PatientsThe Journal of Clinical Psychiatry, 1999
- Molecular Biology of Muscarinic Acetylcholine ReceptorsCritical Reviews™ in Neurobiology, 1996
- Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the ratJournal of Comparative Neurology, 1995
- Cholinergic mechanisms in learning, memory and dementia: a review of recent evidenceTrends in Neurosciences, 1991
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982